Go Pro
→ DOJ Admits It In Court—Your Cash Can Be Seized Without Warning (From Priority Gold) (Ad)tc pixel
NASDAQ:ABP

Abpro 5/15/2025 Earnings Report

Abpro logo
$0.52 0.00 (0.00%)
As of 08/7/2026
ProfileEarnings HistoryForecast

Abpro EPS Results

Actual EPS
-$2.40
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Abpro Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Abpro Announcement Details

Quarter
Date
5/15/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Abpro Earnings Headlines

Abpro Holdings Faces Nasdaq Delisting, Moves to OTC
June 23, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2334035/abpro-holdings-faces-nasdaq-delisting-moves-to-otc/
Abpro Holdings Directors Resign, Board Seeks Replacements
June 22, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/31555/abpro-holdings-directors-resign-board-seeks-replacements/
FDA Clears This Under-$5 Biotech for Phase 2 Clinical Trial
A NASDAQ-listed biotech just cleared a major FDA milestone. Its lead therapy, Lucid-MS, has been cleared for Phase 2 trials in progressive multiple sclerosis. Unlike existing treatments that suppress the immune system, Lucid-MS is designed to protect myelin. In pre-clinical models, it led to movement recovery including walking. Independent research projects peak annual sales up to 5 billion dollars, yet shares still trade under 5 dollars.tc pixel
August 10 at 1:00 AM  |  The Tomorrow Investor (Ad)
ABPO Abpro Holdings, Inc.
May 6, 2026  |  seekingalpha.comhttps://seekingalpha.com/symbol/ABPO
Abpro Bio Co. Ltd.
April 16, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/195990/financials?countrycode=kr
Abpro Holdings Equity Warrant Exp 12th Nov 2029
April 14, 2026  |  cnbc.comhttps://www.cnbc.com/quotes/ABPWW
See More Abpro Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Abpro? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Abpro and other key companies, straight to your email.

About Abpro

Abpro (NASDAQ:ABP) is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.

View Abpro Profile
Earnings Tools